In Brief
A small subset of spinal interneurons labeled by Grp intensity-dependently codes for pain and itch. Accordingly, Sun et al. propose a new model in which Grp + neurons code for itch but inhibit strong pain through a ''leaky gate.''
INTRODUCTION
Pain and itch are two distinct yet related sensations. Both pain and itch are detected by small-diameter dorsal-root ganglia (DRG) neurons and transmitted to the spinal cord dorsal horn, yet they trigger distinct behavioral responses. Pain generates a withdrawal response to avoid tissue damage, while itch elicits scratching to remove irritants. Pain can suppress itch, which is demonstrated when the mechanical pain generated by scratching relieves the itchy sensation (Davidson et al., 2009 ). Itch, however, can rarely suppress pain. On the cellular level, neurons responsive to itchy stimuli in both DRG and the spinal cord can also be activated by pain (Akiyama et al., 2009a; Davidson et al., 2007; Liu et al., 2009; Schmelz et al., 2003) , begging the question of how these two sensations are distinguished.
Debates about pain and itch coding have been ongoing for decades. One major theory, the intensity theory, claims that polymodal sensory neurons respond to both painful and itchy stimuli. The same group of neurons can be stimulated strongly or weakly to generate pain or itch sensations, respectively (Lewis et al., 1927; Von Frey, 1922) . However, weaker painful stimuli or stronger itchy stimuli fail to turn into a different sensation, thus raising questions about the intensity theory (Handwerker et al., 1991; Ochoa and Torebjö rk, 1989; Tuckett, 1982) . Another major theory is the labeled-line theory, which argues that different senses are coded by mutually exclusive populations (Norrsell et al., 1999; Schmelz et al., 1997) . However, the fact that itch-responsive neurons are also activated by painful stimuli argues against the labeled-line theory. A modified labeled-line theory, termed the selectivity theory, incorporates the existence of polymodal sensory neurons (Handwerker, 1992; McMahon and Koltzenburg, 1992) . The selectivity theory suggests that itchy stimuli specifically activate itch-selective neurons to generate itch sensation, while painful stimuli activate both itch-selective neurons and a larger nociceptive population whose activation inhibits itch to produce only pain sensation.
Recent studies largely support this modified labeled-line theory. In DRG, Han et al. (2013) confirmed the existence of ''itchselective'' neurons by showing that the activation of the MrgprA3 + primary sensory neurons generated itch but not pain responses, while its ablation impaired itch and spared pain (Han et al., 2013) . Further along this same labeled line, the ''itch-selective'' neurons in the spinal cord are proposed to be the gastrin-releasing peptide receptor (GRPR)-positive population. The loss of the GRPR + neurons abolished most itch responses but spared pain responses (Sun et al., 2009) . In addition, brain natriuretic peptide (BNP) is suggested to be the itchspecific neurotransmitter, signaling between itch-selective cells in DRG and itch-selective cells in the spinal cord (Mishra and Hoon, 2013) . However, in human psychophysical studies, most chemical-induced itch sensations are accompanied by weaker nociceptive sensations (burning, pricking, stinging, etc.) (LaMotte et al., 2014; Liu et al., 2012; Sikand et al., 2009 Sikand et al., , 2011a . These mixed sensations raise questions about the ''selectivity'' of itch pathways. Although we cannot deny the beauty of simplicity, the anatomical structure of the spinal cord dorsal horn seems to suggest a more complicated and integrative organization of sensory circuits than labeled lines. Unlike pseudo-unipolar DRG neurons, which all serve output functions, only a small subset of superficial dorsal-horn neurons transmit signals further to the brain (Spike et al., 2003) . The remaining majority are interneurons forming interlacing local circuitries whose functions remain largely elusive. Here we attempted to reveal the functions of dorsal-horn circuits as they related to pain and itch. Second-order neurons are the first step in the spinal circuitry, receiving direct synaptic input from DRG neurons. We identified a subset of second-order neurons, positive for Grp, that receive direct synaptic inputs from both pain and itch primary sensory neurons. Surprisingly, the activation of the Grp + neurons generated both pain and itch responses, with the pain coding being intensity dependent. These data led us to this ''leaky gate'' model, which provides a refined theory for pain and itch coding in the spinal cord and better explains results from human psychophysics experiments.
RESULTS

Genetic Labeling of Itch Second-Order Neurons in the Spinal Cord
Previously, we discovered that axons of MrgprA3 + itch primary sensory neurons selectively terminate in lamina II of spinal cord (Han et al., 2013) . To identify genetic markers of second-order neurons that form synapses directly with MrgprA3 + neurons, we utilized transgenic mouse lines with Cre recombinase expression under specific neuronal gene promoters; these lines were generated using bacterial artificial chromosome (BAC)-based transgenic technology by the Gene Expression Nervous System Atlas (GENSAT) project (Gong et al., 2003) . Upon screening all GENSAT Cre lines with expression in the spinal cord dorsal horn, we focused on a promising target, Grp. Grp has previously been implicated in itch transmission. Grp was reported to express in DRG, but not in spinal cord, and had been proposed to provide input to GRPR + neurons (Sun and Chen, 2007) . However, recent studies suggest that Grp instead expresses in spinal cord dorsal horn, not the DRG (Fleming et al., 2012; Solorzano et al., 2015 Figure 1E ), colocalized with IB4 positive fibers in lamina II dorsal inner layer ( Figure 1F ), and partially overlapped with PKCg neurons (9.03%) in ventral inner layer (Braz et al., 2014; Solorzano et al., 2015; Figures 1G and S1E) . Since there are no projection neurons (i.e., dorsal-horn neurons sending their axons to the brain) in lamina II (Todd, 2010) , Grp
Cre line thus labels a subset of interneurons (i.e., neurons whose axons remain and arborize in the spinal cord) in the lamina II inner layer. Regarding neurotransmitter types, more than 90% of Grp + neurons expressed the glutamatergic excitatory marker ( Figures 1H and  1K ) vesicular glutamate transporter (vGlut2); conversely, less than 10% of Grp + neurons overlapped with the GABAergic inhibitory marker GAD1 ( Figure 1I ). Therefore, Grp labels a subset of excitatory interneurons in lamina II inner layer.
To check the prevalence of Grp + neurons in the spinal cord, we stained for pan-neuronal marker NeuN. Grp labeled only 4.24% of neurons in lamina II ( Figure S1 ). Moreover, Grp + neurons were all characterized as vertical neurons according to morphology (n = 16) (Grudt and Perl, 2002; Figures 1J and 1J') . Figure 1D ). Moreover, Grp EGFP colocalized with both MrgprA3 and post-synaptic marker PSD95 ( Figure S1 ), suggesting that Grp + neurons could form synaptic contacts with
MrgprA3-labeled (diagramed in Figure 1L ), itch-selective neurons in DRG (Han et al., 2013) . Figure 2A ).
Grp
To test the behavioral effect of light-mediated activation of the MrgprA3 + neurons, we shone blue light on the shaved nape regions of MrgprA3 Cre ; ROSA26 LSL-ChR2 mice (as diagramed in Figure 2A ). The 1 Hz 100 ms light stimulation generated significant scratching compared with controls ( Figure 2B ; Movie S1). Similar to chemical activation (Han et al., 2013) , optogenetic activation generated only scratching but not wiping behavior, which confirmed the role of MrgprA3 + neurons as itch-selective neurons. The 5 Hz light stimulation, however, failed to elicit scratching above baseline ( Figure 2B , see also Figure S3C ). Consistently, 1 Hz light stimulation reliably evoked action potentials in MrgprA3 + neurons, while 5 Hz light stimulation failed to do so ( Figure S3 ), suggesting that these neurons might not be able to fire at this higher frequency. Figure 2C , see also Figure S3 , monosynaptic connections inferred from no failure of EPSCs to 20 stimuli at 1 Hz), showing that all sampled Grp + neurons labeled a functionally unified population of second-order neurons that appeared to receive direct itchy input from the periphery. When we recorded from surrounding Grp-negative neurons, 25% of them (7/28) also received monosynaptic input, an additional 18% (5/28) received polysynaptic input, and the remaining 57% (16/28) had no connection with MrgprA3 + neurons ( Figure 2D ), suggesting that Grp labels a subset of itch second-order neurons in the spinal cord.
+ Neurons Receive Monosynaptic Input from Both
Itch and Pain Primary Sensory Neurons
We then checked whether Grp + neurons receive input from nociceptors other than pruriceptors in DRG. However, it is hard to selectively activate nociceptors without also targeting the itchselective neurons, given that they share many genetic markers. Therefore, we decided to use monosynaptic rabies tracing (Wickersham et al., 2007) to systemically quantify the inputs to the Grp + population. AAV helper virus (AAV8-LSL-TVA-EGFP-B19G) was injected into the spinal cord to enable expression of TVA receptor and rabies glycoprotein in Cre-expressing neurons. Deficient rabies virus (DG-RV-GFP) then specifically infected TVA-expressing Grp + neurons, which also contained the rabies glycoprotein that allowed transsynaptic labeling (as diagramed in Figure 3A ).
Deficient rabies virus successfully infected Grp + neurons in spinal cord lamina II, but not in Cre-negative mice or when injected without the helper virus ( Figures 3B and S4 ), confirming the specificity of viral tracing. In DRG, rabies virus transsynapti- 3D ). In addition, 50.0% of rabies-labeled neurons were positive for nociceptive marker TrpV1; an available MrgprC11 antibody, which marks most MrgprA3 + itch neurons (Han et al., 2013) , labeled 22.3% of rabies-infected neurons, confirming that Grp + neurons received monosynaptic input from itch-selective neurons (Figure 3D ). Since the nociceptive neuron markers CGRP, IB4, and TrpV1 (which could also be expressed in some pruriceptors) labeled a larger percentage of rabies-infected DRG neurons than the marker for itch neurons, we conclude that Grp + neurons received monosynaptic input from nociceptive populations in addition to itch-selective neurons.
Painful Stimuli Strongly Activate Grp + Neurons, while Itchy Stimuli Weakly Activate Grp + Neurons
Since our results suggest that Grp + neurons receive direct synaptic inputs from both itch and pain primary sensory neurons, we next tried to determine whether Grp + neurons can distinguish between painful and itchy inputs. We performed DRGattached spinal slice recordings and applied drugs on DRG cell bodies to mimic natural painful and itchy stimuli coming from the periphery ( Figure 4A ). Both pain-and itch-producing drugs applied directly on DRG triggered action potentials in Grp + neurons ( Figures 4C-4F ). Capsaicin evoked high-frequency firing in Grp + neurons, while the pruritogen SLIGRL produced only weak firing on the same recorded neurons, even at very high doses. To ensure that limited penetration of peptide SLIGRL did not affect the responses of Grp + neurons, we applied the small-molecule pruritogens histamine and chloroquine. Similarly, histamine and chloroquine generated weaker firing in Grp + neurons than capsaicin (p < 0.001 and p < 0.001, respectively; two-way ANOVA), which indicates that these neurons fire strongly in response to painful stimuli but (n = 5, 0.5 mM; n = 5, 2 mM; n = 6, 5 mM), (D) SLIGRL (n = 7, 100 mM; n = 6, 500 mM), (E) chloroquine (CQ) (n = 9, 3 mM; n = 10, 10 mM), and (F) histamine (n = 5, 10 mM; n = 9, 50 mM) application on DRG. Black bar indicates duration of drug application (n = 6). Data are represented as mean ± SEM.
weakly in response to itchy stimuli (diagramed in Figure 4B ). Consistent with our results, several previous studies showed that spinal interneurons and projection neurons fired at higher frequencies in response to painful stimuli than in response to itchy stimuli (Akiyama et al., 2009b; Davidson et al., 2007 Davidson et al., ,2012 .
Coding of Both Pain and Itch by Grp + Neurons
Although the itch neurons in DRG are responsive to both painful and itchy stimuli, activation of these neurons generates itch and not pain responses (Han et al., 2013 neurons. Drugs known to produce pain (capsaicin) and itch (gastrinreleasing peptide, GRP, and brain natriuretic peptide, BNP) were first tested intrathecally in wild-type mice. Previous studies reported mixed licking, biting, and scratching responses to capsaicin (Hunskaar et al., 1985; Yaksh et al., 1979) . Counting licking and biting together separately from scratching revealed that responses in mice were predominantly licking and biting, with very few bouts of scratching (Hunskaar et al., 1986) . To further distinguish licking, indicating pain, and biting, indicating itch, behaviors were recorded with a high-definition camera and four side mirrors to enable views from all angles ( Figure S5 ; LaMotte et al., 2011) . When played back at 1/4 normal speed, licking but not biting responses were detected following injections of capsaicin. Short-lasting licking responses (<5 min) directed to the lower back regions were predominantly observed at a characteristic frequency of 5 Hz and were accompanied by minor scratching responses, as previously reported ( Figure 5B ) and only pain-related licking in wild-type mice ( Figures  5B and 5C ), which confirms the specificity of the activation responses. The licking responses lasted only about 4 min after injection (similar to the licking responses in wild-type mice) and -GRP (19-27) (n = 6 and 5); 10 mg or 33.3 nmol capsaicin, n = 8; 10 mg or 33.3 nmol capsaicin with naloxone (1 mg or 3.33 nmol, n = 7), naltrindole (10 mg or 24.1 nmol, n = 7), CTAP (5 mg or 13.7 nmol, n = 6), CTOP (10 mg or 9.43 nmol, n = 6), bicuculline (10 mM or 0.1 nmol, n = 7), cyclosomatostatin (0.1 mM or 1 nmol, n = 8), and for (F) 5 mg/mL or 0.16 nmol capsaicin without (n = 6) and with naloxone (1 mg or 3.33 nmol, n = 9). (H and I) Pain (H) and itch (I) dose-response curve fitting of (D) and (E). Data are represented as mean ± SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; two-tailed unpaired Student's t test. Abbreviations are as follows: WT, short for wild-type; KO, short for TrpV1 À/À ; Grp-V1;V1KO, short for Grp Cre ; ROSA26 ; TrpV1
were not affected by intrathecal injection of a GRPR antagonist ( Figure 5F ). The scratching responses lasted more than 30 min and were effectively blocked by GRPR antagonist ( Figure 5G) ; this is consistent with the critical role of GRPR neurons in itch transmission (Sun et al., 2009; Sun and Chen, 2007) . Thus, the activation of Grp + neurons can trigger both robust pain and itch responses, a phenomenon rarely observed. Grp + neurons appear to receive monosynaptic inputs from both itch and pain neurons and to code for both itch and pain, showing unexpected convergence of two related sensations in the spinal cord.
Intensity-Dependent Coding of Pain by Grp + Neurons Next, we examined the relationship between neuronal activation and behavior by determining the behavioral effects of various doses of capsaicin. Itch responses monotonically increased until a plateau was reached and were fitted to the Hill equation (R 2 = 0.97, Figures 5E and 5I ). Pain responses, surprisingly, showed an inverted U relationship ( Figure 5D ). Increased amounts of capsaicin resulted in increased licking time that peaked and then decreased with higher capsaicin doses; weak and strong activation produced little pain behavior while medium range activation generated the greatest pain responses. Not surprisingly, pain dose responses were fitted well with a polynomial equation (R 2 = 0.99, Figure 5H ). Given that high doses of capsaicin still caused robust itch responses, the inverted U pain responses were unlikely to be caused by desensitization. Thus, Grp + neurons demonstrate intensity-dependent coding. Rather than generating itch sensation with weak activation and pain sensation with strong activation, as suggested by the original intensity theory, Grp + neurons monotonically code for itch while pain is coded only by inputs of medium intensities. We reasoned that the inverted U coding of pain could be generated by a combination of direct coding effects and another pain inhibition circuit. To uncover this pain inhibition mechanism, we attempted to ''rescue'' pain responses during strong activation of the Grp + neurons. An opioid antagonist, naloxone, at a dose not eliciting pain itself, ''rescued'' the pain responses from almost zero to about half of the maximal level. Both bicuculline, a GABA A antagonist, and cyclo-somatostatin, the antagonist of antinociceptive somatostatin highly expressed in the surrounding region, failed to ''rescue'' the pain responses ( Figure 5F ). Successfully rescuing pain responses again confirmed that Grp + neurons were not desensitized by high doses of capsaicin. To demonstrate that naloxone was not simply blocking the basal activity of the endogenous opioid system independent of Grp activation, we coinjected naloxone with a low dose of capsaicin, which can produce both medium pain and itch responses. No effect was observed on pain responses ( Figure 5F ), indicating that the endogenous opioid system was only recruited to inhibit pain during strong activation of the Grp + neurons. Thus, the endogenous opioid system is at least partially responsible for the pain inhibition associated with strong activation of the Grp + neurons and therefore, together with direct pain coding by the Grp + neurons, generates this inverted U response curve. We then determined which endogenous opioid peptide was employed to block pain by utilizing the mu opioid antagonists CTAP and CTOP and the delta opioid antagonist naltrindole.
Naltrindole, but not CTAP or CTOP, induced a similar rescue effect as naloxone ( Figure 5F ), while none of the drugs affected itch responses ( Figure 5G ). These results suggest that enkephalin, the endogenous ligand for delta opioid receptors, was recruited by Grp + neurons to inhibit pain, but not itch, which is consistent with previously reported enkephalin effects (Lee and Ko, 2015) . On the contrary, another endogenous opioid, dynorphin, was reported to inhibit itch, but not pain (Kardon et al., 2014) . Colocalization of Grp, enkephalin, and synaptic marker PSD95 also suggests that enkephalin-expressing interneurons may be synaptically connected to Grp + neurons ( Figure S5 ). To directly test this, we utilized Penk Cre line to label enkephalin-expressing neurons in the spinal cord and verified the expression of enkephalin in these inhibitory interneurons ( Figures 6D and 6E) , as previously reported (Fukushima et al., 2011; Todd et al., 1992 ) treated with high-dose capsaicin released a minimal amount of enkephalin, which confirms that the release of enkephalin is dependent on strong activation of the Grp + neurons. Moreover, enkephalin requires strong depolarization for release (Cesselin et al., 1984; Neuman et al., 1984) , consistent with the observation that only strong activation of the Grp + neurons triggers pain inhibition.
Grp
+ Neurons Form Leaky Gate to Negatively Regulate
Pain Transmission Activation of the Grp + neuron population codes for pain but also inhibits pain through the release of enkephalin, which forms a type I incoherent feedforward loop (FFL) (summarized in Figure 7B ) featuring non-monotonic output (Alon, 2007; Milo et al., 2002) . An example of a pain-related type I incoherent FFL can be found in the gate control theory (Braz et al., 2014; Duan et al., 2014; Melzack and Wall, 1965; Wall, 1978) . The gate control theory of pain proposes that nociceptive transmission neurons (T) receive both noxious input from C fibers and nonnoxious input from Ab fibers. Ab input also indirectly inhibits nociceptive transmission neurons through inhibitory interneurons (IN), thus forming a type I incoherent FFL that can close the gate (T) and suppress painful input ( Figure 7A ). The somatostatin-and dynorphin-expressing interneurons have recently been implicated as transmission neurons and inhibitory interneurons, respectively, in the gate control theory (Duan et al., 2014) .
Here, we present a model to explain our experimental observations and then provide more data to support the model. In the same way as Ab fibers in the gate control theory, we propose that Figure 8A ). Diptheria toxin treatments successfully ablated more than 95% of the Grp + neurons (Figures 8B and 8C ). Crenegative mice (ROSA26 LSL-DTR/LSL-tdTomato ) treated with same doses of diphtheria toxin were used as controls. Ablated mice were healthy and had normal motor coordination in the rotarod test ( Figure S6 ). In addition, CGRP-and IB4-labeled lamina II regions showed no change after ablation, indicating that the loss of such a small population did not obviously affect the general organization of the local circuitries. The number of PKCg-positive neurons was reduced, consistent with the partial overlap between PKCg and Grp + neurons, while the number of Pax2 + interneurons was comparable between ablated and control mice, confirming that diphtheria toxin treatment did not produce nonspecific neurotoxicity ( Figure S6 ).
First, we tested acute pain responses. Pain behavioral responses induced by injection of capsaicin into both the cheek and intraplantar surface of the hindpaw greatly increased after ablation ( Figure 8E, yellow (Figure 8D) . Interestingly, GRPR antagonist significantly blocked histamine-and chloroquine-induced itch in control mice but did not further reduce scratching responses in Grp-neuron-ablated mice. This suggests that the residual itch responses after Grp neuron ablation are mediated by a GRPR-independent pathway ( Figure 8E ).
Strong Pain Responses Are More Affected by the Loss of Grp + Neurons
Unlike in the gate control theory, only strong activation of the Grp + neurons closes the leaky gate to inhibit pain. Therefore, the leaky gate model predicts that weak painful stimuli might trigger less or no inhibition. Accordingly, we compared chemical pain responses (capsaicin-induced cheek wiping) with two different doses. Highdose capsaicin (1 mg/mL) produced significantly more cheek wiping in ablated mice ( Figure 8E , yellow shaded), while lowdose capsaicin (0.5 mg/mL) generated similar amounts of wiping in both ablated and control mice ( Figure 8F ), matching our prediction that weak pain triggers no inhibition from the Grp FFL. Similarly, intraplantar injection of high-dose capsaicin (0.1 mg/mL) induced significantly more licking and flinching responses, indicating pain, in ablated animals, while low dose (0.05 mg/mL) triggered comparable responses. We also tested thermal pain using both hot plate and tail immersion, with two temperatures. Ablated mice showed reduced response latencies at both temperatures ( Figures 8G and 8H) . Therefore, we compared the ratios of ablated responses to control responses at the two temperatures, with a lower ratio meaning a larger increase in pain response after ablation. The ratios at high temperature were significantly lower than the ratios at low temperature in both tests, suggesting that thermal stimuli at higher temperatures resulted in larger increase in pain response after the loss of Grp + neurons, consistent with the leaky gate model.
We also compared dose effect on itch responses, which are normally coded by the Grp + neurons, between control and ablated mice. Ablated mice showed reduced itch responses to low doses of SLIGRL and CQ ( Figure 8D ), while high doses generated similar responses in both ablated and control mice (Figure S6) . Thus, in contrast to pain, stronger itch responses are less affected by the loss of Grp + neurons, potentially due to saturation or compensation from other itch second-order neurons. These results confirm that the Grp FFL has distinct roles in pain and itch coding.
DISCUSSION
The selectivity theory depicts pain and itch coding in the spinal cord as the continuation of separate labeled lines from periphery, with pain inhibiting itch through B5-I interneurons (Kardon et al., 2014) and NPY interneurons (Bourane et al., 2015) . Here, we present experimental observations and a new ''leaky gate'' model to expand the current coding theory of pain and itch. In combination with selectivity theory, the leaky gate model can provide better descriptions of pain-and itch-related phenomena. The data show that a subset of second-order neurons with uniform morphologies, the Grp + population, participates in the coding of both pain and itch sensations; this potentially represents the currently underappreciated crosstalk of different sensations in the spinal cord. Another feature of the Grp + population is the intensity-dependent coding of pain. The Grp + neurons directly code for pain sensation and, upon strong activation, indirectly inhibit pain via the recruitment of the endogenous opioid system. The classic intensity theory suggests that pain and itch sensations are differentially coded by strong and weak activation intensities. Here, we propose that the intensity-dependent pain coding by Grp + neurons is a form of negative regulation of pain in the spinal cord. This novel intensity-dependent coding serves as a good example of the currently overlooked non-monotonic signal processing in spinal circuits. 
(legend continued on next page)
Consistent with the intensity-dependent coding of Grp + neurons, we observed dose-dependent behavioral changes after the loss of Grp + neurons (Figures 8 and S6 ), suggesting that testing of multiple doses in behavioral assays could help to identify currently overlooked nonlinearity in pain and itch coding. Notably, the drug doses utilized in pain and itch behavioral tests in our study, and in the pain and itch field, were high compared with cellular studies. The specificities of these responses were largely established by previous work with respective pruritogen receptor knockouts (Han et al., 2006; Liu et al., 2009 Liu et al., , 2011 . However, receptor knockouts usually reduce, but not abolish, scratching responses, suggesting potential nonspecific effects associated with high doses in behavioral tests. The number of activated neurons or ligand-bound receptors needed to trigger behavior responses remains an open question in the field. Yet the higher doses used in behavioral tests compared with cellular assays could be at least partially explained by dilution, tissue penetration, and the differential receptor densities between nerve terminals and cell bodies. In addition, human psychophysical studies, in which subjects can orally report sensations, usually require lower doses (LaMotte et al., 2011; Sikand et al., 2011b) than animal behavioral assays, indicating the relative low sensitivity of animal behavioral tests. Grp + neurons appear to receive monosynaptic input from both pain-and itch-sensing primary populations, yet painful stimuli strongly activate Grp + neurons while itchy stimuli weakly activate them. The weaker, pruritogen-mediated activation of Grp + neurons could be due to factors including the weak activation of DRG neurons by itchy stimuli, weak synaptic connections, or a small percentage of itch-responsive primary neurons. This weak activation by itchy stimuli is consistent with the failure to detect chloroquine-induced c-fos activity in Grp + neurons (Bell et al., 2016 ). Yet unlike enkephalin-expressing inhibitory interneurons, which require strong depolarization to release neuropeptides, the weak activation of Grp + neurons by pruritogens seems sufficient to trigger GRP release from these excitatory interneurons. In addition to Grp + neurons, some lamina II interneurons may receive monosynaptic itchy input. In lamina I, projection neurons and GRPR + interneurons might also receive direct itchy input, warranting future research to further dissect related spinal cord circuits. Pain detection systems need to be sensitive enough to protect the body from potential harm, but when exposed to strong painful stimuli, high sensitivity may generate too much pain and interfere with proper behavioral responses. Thus, brakes are necessary. Brakes triggered by signals from Ab mechanosensitive fibers make gentle rubbing an effective way to relieve pain. The Grp FFL also functions as a brake for pain generated by Grp + population and parallel pain pathways. It positively codes for pain and triggers enkephalin release only in response to strong activation, which is consistent with dependence of enkephalin release on strong depolarization. This prominent enkephalin-mediated pain inhibition can completely block pain responses from the Grp + population and further reduce pain coded by parallel pain pathways in the spinal cord; thus, its high triggering threshold ensures sensitivity to weak painful input. Meanwhile, the pain inhibition mediated by Grp FFL cannot be triggered by itch because itch stimuli only weakly activate Grp + neurons, consistent with the fact that itch can rarely inhibit pain.
The ablation experiments showed that stronger pain responses had larger increases after the ablation of the Grp + neurons, suggesting that the Grp FFL provides stronger inhibition on stronger painful input in physiological conditions, as predicted by the leaky gate model. Theoretically, weak enough painful stimuli would be positively coded by Grp + neurons without triggering pain inhibition. Thus, these pain responses might be weaker after the ablation of Grp + neurons. However, given that the Grp + neurons only represent a subset of pain-responsive neurons in the spinal cord, the loss of these neurons may generate a more subtle change in behavior when compared with the loss of the strong pain inhibition effect mediated by the Grp FFL and thus may be much harder to detect with animal behavioral tests. In a previous study, Mishra and Hoon (2013) ablated 70% of NPR1 + neurons, which were reported to be a subset of Grp + neurons, with BNP-conjugated saporin and found a significant change in histamine responses. We believe the partial loss of Grp + neurons might not be sufficient to generate significant changes in pain responses; however, a trend of increase in pain responses from hot plate test was observed after the ablation of NPR1 + neurons. The Grp + neurons represent a subset of second-order neurons that mediate pain and itch sensations in the spinal cord. Painful stimuli from the periphery can elicit both pain and itch responses via the Grp + neurons. The itch responses are likely blocked by feedforward inhibition from parallel pain pathways, as noted by the selectivity theory. Similarly, itchy stimuli from the periphery can also trigger both itch and pain responses via the Grp + neurons. We think this pain responses might be weak, as Grp + neurons were only weakly activated by itchy stimuli. Indeed, in human psychophysical studies, most itchy substances induce itch sensation accompanied by weaker pain sensations such as pricking and burning, while painful substances induce nociceptive but not itch sensations (LaMotte et al., 2014; Liu et al., 2012; Sikand et al., 2009 Sikand et al., , 2011a . Even if we cannot rule out the possibility that mechanical or other forms of itch can bypass or block the weak pain responses and result in pure itch sensation, the leaky gate model can explain the nociceptive sensations generated by itchy chemicals in human psychophysics studies.
(F) Pain responses from capsaicin cheek injections (1 mg/mL or 33 nmol, n = 8; 0.5 mg/mL or 16.7 nmol, n = 7 versus 6), capsaicin intraplantar injections (0.1 mg/mL or 3.3 nmol, n = 6; 0.05 mg/mL or 1.67 nmol, n = 6), and immersion assay (50 C, n = 7 versus 6; 52 C, n = 7 versus 6) in Grp Cre ;
ROSA26 LSL-DTR; LSL-tdTomato (red) and ROSA26 LSL-DTR; LSL-tdTomato control mice (blue).
(G and H) Pain responses from (G) hot plate test (52 C, n = 10; 55 C, n = 7 versus 6) and Hargreaves test (n = 8 versus 7) as well as (H , CQ is short for chloroquine, and 5-HT is short for serotonin.
In summary, Grp + neurons positively code for itch while negatively regulating pain transmission with a ''leaky gate.'' This study, to our knowledge, experimentally demonstrates intensity-dependent coding of pain in the spinal cord for the first time. Our leaky gate model builds on current theories of pain and itch coding and further refines them. It better explains observations in human psychophysical studies and serves as an example of non-monotonic coding and crosstalk of sensory information in the spinal cord. Further studies of the Grp + -related circuits in chronic pain and itch conditions might uncover relevant changes contributing to these pathological conditions.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Xinzhong Dong (xdong2@jhmi.edu). All behavioral tests were performed with an experimenter blind to genotype. The mice were 2-4-month-old males that had been backcrossed to C57BL/6 mice for at least six generations. The day before the behavioral tests, all mice were acclimated for at least 30 min to their testing environment. We housed 4-5 mice in each cage in the vivarium with 12h light/dark cycle and all the behavioral tests were performed in the morning.
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mouse Lines
METHOD DETAILS
Immunofluorescence 2-4 month old mice were anesthetized with pentobarbital and perfused with 20 mL 0.1 M PBS (pH 7.4, 4 C) followed with 25 mL of fixative (4% formaldehyde (vol/vol) and 14% sat. picric acid (vol/vol) in PBS, 4 C). Spinal cord and DRG were dissected from the perfused mice. DRG was postfixed in fixative at 4 C for 30 min, and spinal cord were fixed for 1 hr. Tissues were cryoprotected in 30% sucrose (wt/vol) for more than 12 hr and were sectioned with a cryostat. The sections on slides were dried at 37 C for 40 min, and fixed with 4% paraformaldehyde at room temperature for 10 min. The slides were preincubated in blocking solution (10% normal goat serum (vol/vol), 0.2% Triton X-100 (vol/vol) in PBS, pH 7.4) for 1 or 2 hr at room temperature, then incubated overnight at 4 C with primary antibodies. Secondary antibody incubation was performed at room temperature for 2 hr. For primary antibodies, we used rabbit a-CGRP (T-4239, Peninsula, 1:1,000), rabbit a-NF200 (AB1982, Chemicon, 1:1,000), rabbit a-PKCg (sc-211, Santa Cruz Biotechnology, 1:1,000), rabbit a-GFP (A-11122, Molecular Probes, 1:1,000), mouse a-Neuronal nuclei (MAB377, Chemicon, 1:200), mouse a-PSD95 (K28/43, NeuroMab, 1:500), rabbit a-PSD95 (EP1183Y, Millipore, 1:500), guinea pig a-TrpV1 (AB5566, Millipore, 1:200), rabbit a-MrgprC11 (made by our lab, 1:200), mouse a-GAD1 (MAB 5406,Millipore, 1:2000) and mouse a-Enkephalin (NOC1, Millipore, 1:100). For secondary antibodies, we used goat a-rabbit (A11008, Alexa 488 conjugated; A11011, Alexa 568 conjugated; A21245, Alexa 647 conjugated, Thermo Fisher), goat a-mouse (A11001. Alexa 488 conjugated; A11004, Alexa 568 conjugated; A21236, Alexa 647 conjugated, Thermo Fisher) and goat a-guinea pig (A11075, Alexa 568 conjugated). All secondary antibodies were diluted 1:500 in blocking solution. To detect IB4 binding, sections were incubated with Griffonia simplicifolia isolectin GS-IB4 (1:500; I21411, Alexa 488 conjugated; I21412, Alexa 568 conjugated, Thermo Fisher).
Electrophysiological Recordings
To prepare spinal cord slices, 4 to 6 week-old mice were deeply anesthetized with 2% isoflurane (Abbott Laboratories, North Chicago, IL, USA). Spinal cord with dorsal root or DRG was rapidly removed and placed in ice-cold, low-sodium Krebs solution that contained: 95mM NaCl, 2.5mM KCl, 26mM NaHCO 3 , 1.25mM NaH 2 PO 4 -H 2 O, 6mM MgCl 2 , 1.5mM CaCl 2 , 25mM glucose, 50mM sucrose, 1mM kynurenic acid bubbled with 95% O 2 /5% CO 2 . Sagittal spinal cord slices (400 mm) with dorsal roots or DRG attached were cut by a Vibratome (VT1200, Leica Biosystems, Buffalo Grove, IL, USA) and transferred to low-sodium Krebs solution without kynurenic acid for recovery at 34 C for 45 min and then at room temperature for an additional 1 hr before being used for recordings.
For electrophysiology recording, slices were stabilized with a nylon harp and submerged in a low-volume recording chamber (SD. Instruments, San Diego, CA, USA), which was perfused with Krebs solution (125mM NaCl, 2.5mM KCl, 26mM NaHCO 3 , 1.25mM NaH 2 PO 4 -H 2 O, 1mM MgCl 2 , 2mM CaCl 2 , 25mM glucose) at a rate of 5ml/min bubbled with 95% O2/5% CO2. Whole-cell patchclamp recording of Grp + neuron was carried out under oblique illumination with an Olympus fixed-stage microscope system (BX51, Melville, NY, USA). Using a puller (P1000, Sutter, Novato, CA, USA), we fabricated thin-walled glass pipettes (World Precision Instruments, Sarasota, FL, USA) that had a resistance of 3-6 MU and were filled with internal solution (120mM K-gluconate, 20mM KCl, 2mM MgCl 2 , 0.5mM EGTA, 2mM Na 2 -ATP, 0.5mM Na 2 -GTP, and 20mM HEPES). The cells were voltage clamped at -70 mV. Membrane current signals were sampled at 10kHz and low-pass filtered at 2 kHz. We monitored R series and R input and discarded cells if either of these values changed by more than 20%.
DRGs were collected from mice, which were deeply anesthetized with 2% isoflurane (Abbott Laboratories, North Chicago, IL, USA) and put in cold DH10 medium (DMEM/F-12 with 10% fetal bovine serum and 1% penicillin/streptomycin, GIBCO) and treated with enzyme solution (5mg/ml dispase and 1mg/ml collagenase Type I in HBSS without Ca 2+ Spinal cords were cut into three sagittal sections and then recovered in oxygenated ACSF for about 1 hr at 37 C. Three sections were subsequently incubated with 200 mL oxygenated Krebs solution (125 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 -H 2 O, 1 mM MgCl 2 , 2 mM CaCl 2 , 25 mM glucose) with capsaicin (2 mg/mL, 5 mg/mL and 0 mg/mL, respectively) and proteinase inhibitor mix (1 mM phosphoramidon, 1 mM captopril, and 0.1% BSA) for 15 min at 37 C. 100 mL of ACSF from each sample was then used for the detection of Enkephalin release. ELISA detections of enkephalin were performed following manufacturer's protocol (FEK02421, Phoenix Pharmaceuticals). Results were normalized to the weight of the tissue. At least six mice were used for each condition. [19] [20] [21] [22] [23] [24] [25] [26] [27] , 200 mM or 2 nmol/ site) or saline (50 ml) were injected 10 min before pruritogen injection when indicated. Behavioral responses were video recorded for 30 min. The video recording was subsequently played back in slow motion and the number of bouts of scratching with the hindpaw and directed toward the injection site, were counted.
Behavioral Testing
For the hot plate test, a clear plexiglass cylinder was placed on the plate and the mice were placed inside the cylinder. The onset of brisk hindpaw lifts and/or flicking/licking of the hindpaw was assessed at different temperatures.
For the tail immersion test, mice were gently restrained in a 50 mL conical tube into which the mice voluntarily entered. The protruding one-third of the tail was then dipped into a water bath of varying temperatures. The latency to respond to the heat stimulus with vigorous flexion of the tail was measured.
For the Hargreaves test, mice were placed under a transparent plastic box (4.5 3 5 3 10 cm) on a glass floor. The infrared source was placed under the glass floor and the infrared light was delivered to the hindpaw. The latency for the animal to withdraw its hindpaw was measured.
For the Von Frey filament test, mice were placed under a transparent plastic box (4.5 3 5 3 10 cm) on a metal mesh. Von Frey filaments, each delivering a different bending force, were applied to the hind paw using the up-down method and the threshold force corresponding to 50% withdrawal was determined.
For the chemically induced pain test, 10 mL of capsaicin and 7 mL of capsaicin were injected in cheek and paw respectively and the numbers of front paw wipes or the time of licking/flinching responses were counted in 10 min.
For the rotarod test, each mouse was trained for 5 min at a constant speed of 4 rpm on the rotarod (Rotamex, Columbus Instruments). The first trial started at least 1 hr after training. Every day, each mouse received three trials, separated by 30 min, at speeds accelerating from 4 to 40 rpm (with a 4 rpm increase every 30 s). Each mouse was tested for 3 consecutive days. The trial was finished when the mouse fell off the rotarod. The latency to falling off the rotarod was recorded and used in subsequent analyses.
For specific activation of Grp + neurons, Grp Cre ; ROSA26 ; TrpV1 À/À mice were intrathecally injected with different amounts of capsaicin or capsaicin with naloxone (0.1 mg/mL), naltrindole (0.2 mg/mL), CTAP (0.5 mg/mL), CTOP (1 mg/mL), cycloSOM (0.1 mM) and bicuculline (10 mM). Lumber puncture were made with 30 gauge needles and drugs at 10 mL of volume were delivered. Lower back regions of mice were shaved a day before injections. High definition videos were recorded from the top for 30 min with four mirrors to enable views of all angles. Video recordings were subsequently played back at 1/5 normal speed. LSL-ChR2 mice were used as controls. Scratching bouts were counted in 5 min time periods. Sham operations without blue light were used to determine baseline scratch numbers.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as mean ± SEM. n represents the number of mice analyzed. The distribution of the variables in each experimental group was assumed normal. Most statistical comparisons were conducted by two-tailed, unpaired Student's t test. Two-way ANOVA followed by post hoc Student-Newmann-Keuls tests were used for comparison between capsaicin and pruritogen-induced responses. Extended Welch's t test was used for the comparison of ratios of ablated responses and control responses, where Student's t tests and ANOVA tests could not apply. Power analysis was used to justify the sample size. No data were excluded.
Differences were considered to be statistically significant for p < 0.05. Representative data are from experiments that were replicated biologically at least three times with similar results. Statistical analysis done with R. Extension of Welch's t test: m1h: mean of log value of ablated responses, high dose; m1l mean of log value of ablated responses, low dose; m2h: mean of log value of control responses, high dose; m2l: mean of log value of control responses, low dose. Null hypothesis H 0 : (m1h À m2h) À (m1l À m2l) = 0. Alternative H 1 : (m1h À m2h) À (m1l À m2l) > 0. Test statistics: t = ððm1h À m2hÞ À ðm1l À m2lÞ=sÞ, where m denotes the sample means of the subgroup. s = ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ðs1h 2 =n1hÞ + ðs1l 2 =n1lÞ + ðs2h 2 =n2hÞ + ðs2l 2 =n2lÞ p , where s 2 denotes the sample variance and n is the sample size. Under H 0 , the test statistics follows t-distribution and the degrees of freedom, df = s1h 
